Since the patients in the study were given adjuvant treatment with TAM or no adjuvant treatment it was possible to compare the effect of TAM in patients with ER+ breast tumors expressing either low levels (−/+) or high (++/+++) levels of the Wnt-5a protein. Here, WNT5A is linked to breast neoplasm.